Breast Cancer – Nancy Lin, MD, and Robert Figlin, MD, discuss novel agents and recent clinical developments in breast cancer from ASCO20 - a podcast by OBR Peer-Spectives
from 2020-06-28T02:06:32
::
::
Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Nancy Lin, MD, Associate Professor of Medicine, Harvard Medical School Associate Chief, Division of Breast Oncology Dana-Farber Cancer Institute, discuss novel agents and recent clinical developments in breast cancer
Further episodes of OBR Peer-Spectives
Further podcasts by OBR Peer-Spectives
Website of OBR Peer-Spectives